Related Experiment Video
Updated: Mar 28, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Gamma glutamyltransferase, inflammation and cardiovascular risk factors in isolated coronary artery ectasia
Abdullah Dogan1, Akif Arslan1, Habil Yucel1
1Cardiology Department, Medical School, Suleyman Demirel University, Isparta, Turkey.
Insights
Coronary artery ectasia (CAE) is linked to higher obesity, gamma glutamyltransferase (GGT), and high-sensitivity C-reactive protein (hs-CRP) levels. However, CAE shows an inverse association with diabetes, and its severity correlates with GGT and hs-CRP.
Area of Science:
- Cardiology
- Vascular Biology
- Biomarkers
Background:
- Conflicting data exists on cardiovascular risk factors in coronary artery ectasia (CAE).
- The association between CAE, high-sensitivity C-reactive protein (hs-CRP), and gamma glutamyltransferase (GGT) remains unclear.
Purpose of the Study:
- To investigate major cardiovascular risk factors, serum GGT, and hs-CRP levels in a large cohort of patients with CAE.
- To clarify the relationship between CAE and these biomarkers and risk factors.
Main Methods:
- Retrospective analysis of 167 patients with isolated CAE and 150 controls undergoing coronary angiography.
- Evaluation of cardiovascular risk factors (family history, obesity, smoking, diabetes, hypertension, hyperlipidemia) and serum GGT and hs-CRP levels.
Main Results:
- CAE patients showed higher prevalence of hypertension and obesity, and lower frequency of diabetes compared to controls.
- Serum GGT and hs-CRP levels were significantly higher in CAE patients than in controls (p=0.001 for both).
- CAE was independently associated with obesity (OR: 2.84), GGT (OR: 1.08), and hs-CRP (OR: 3.1), but inversely with diabetes (OR: 0.44). GGT and hs-CRP levels correlated with ectasia severity.
Conclusions:
- Coronary artery ectasia (CAE) is independently associated with obesity, elevated GGT, and hs-CRP levels.
- An inverse relationship exists between CAE and diabetes.
- The severity of CAE may be positively correlated with GGT and hs-CRP levels.
Introduction And Objective:
There are conflicting data on the prevalence of cardiovascular risk factors in coronary artery ectasia (CAE). It is unclear whether CAE is associated with high-sensitivity C-reactive protein (hs-CRP) and gamma glutamyltransferase (GGT). We therefore investigated major cardiovascular risk factors, serum GGT and hs-CRP levels in a large population of patients with CAE.
Methods:
A total of 167 patients with isolated CAE and 150 controls with normal coronary arteries were selected from 10505 patients undergoing coronary angiography. Serum GGT and hs-CRP levels were evaluated in addition to cardiovascular risk factors including family history, obesity, smoking, diabetes, hypertension and hyperlipidemia.
Results:
Hypertension and obesity were slightly more prevalent in CAE patients than in controls, whereas diabetes was slightly less frequent in CAE patients. Other risk factors were similar. Serum GGT (22 [17-42] vs. 16 [13-21] U/l, p=0.001) and hs-CRP (2.9 [1.9-3.6] vs. 1.4 [1.1-1.8] mg/l, p=0.001) levels were higher in CAE patients than in controls. The presence of CAE was independently associated with diabetes (OR: 0.44, 95% CI: 0.20-0.95, p=0.04), obesity (OR: 2.84, 95% CI: 1.07-7.56, p=0.04), GGT (OR: 1.08, 95% CI: 1.03-1.12, p=0.001) and hs-CRP levels (OR: 3.1, 95% CI: 2.1-4.6, p=0.001). In addition, GGT and hs-CRP levels were higher in diffuse and multivessel ectasia subgroups than focal and single-vessel ectasia subgroups (each p<0.05).
Conclusions:
Our findings show that CAE can be independently and positively associated with obesity, GGT and hs-CRP levels, but inversely with diabetes. Moreover, its severity may be related to GGT and hs-CRP levels.
Related Concept Videos
Coronary Artery Disease I: Introduction
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease I: Introduction
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations

